Smith & Nephew plc
SN.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.09B
Close$
Share Statistics
| Market cap | $11.09 Billion |
|---|---|
| Enterprise Value | $14.13 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 21.77% |
|---|---|
| Return on Assets | 10.24% |
| Return on Invested Capital | 19.89% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.15 |
| Enterprise Value to EBIT | 7.93 |
| Enterprise Value to Net Income | 12 |
| Total Debt to Enterprise | 0.27 |
| Debt to Equity | 0.73 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.35
Average shareholder expectationRevenue Estimate
$2.61 B
Average shareholder expectationNext Earnings Call
Expected Date
February 23, 2027
EPS Estimate
$0.46
Average shareholder expectationRevenue Estimate
$2.51 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Smith & Nephew plc
18,362 employees
CEO: Roland Diggelmann Smith & Nephew plc, along with its subsidiaries, operates globally as a developer, manufacturer, marketer, and seller of medical technology. Its orthopaedic division offers knee implants for replacement procedures and hip implants for jo...